| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-01-31 | FY 2023
FILED 2024-01-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.61B | $1.43B | $1.31B |
| YoY Revenue Growth % | +12.7% | +9.3% | — |
| Gross Profit | $1.34B | $1.18B | — |
| Gross Margin % | 83.2% | 82.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $56.8M | -$162.6M | -$164.7M |
| Operating Margin % | 3.5% | -11.4% | -12.6% |
| Net Income (GAAP) | $282.3M | -$73.7M | -$89.9M |
| EBITDA (Normalized) | $72.0M | -$150.6M | -$117.6M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $371.2M | $320.6M | $299.1M |
| Capital Expenditures (CapEx) | $19.0M | $14.9M | $58.9M |
| Free Cash Flow (FCF) | $352.2M | $305.6M | $240.2M |
| FCF Margin % | 21.9% | 21.4% | 18.4% |
| Return on Invested Capital (ROIC %) | 2.6% | -9.0% | -5.5% |
| Cash & Short-Term Equivalents | $871.2M | $879.2M | — |
| Total Debt (Short + Long Term) | $493.5M | $458.8M | $924.3M |
| Total Stockholders' Equity | $2.08B | $1.85B | $1.90B |